Ligand Pharmaceuticals, Inc.

$110.77
LGND - NASDAQ
Dividend yield
Average yield for past twelve months.
-
P/E ratio
-
Payout ratio
Proportion of net income paid out as dividends to shareholders
-
Yearly
Company profitability (EPS)
-
past 12 months
CASH payout ratio
Ligand Pharmaceuticals, Inc. last quarter cash income being paid in the form of dividends.
Last quarter
Become our supporter to unlock all data!
Stock volatility (Beta)
See how volatile LGND stock is compared to other dividend stocks and to its sector
past 12 months
Become our supporter to unlock all data!
Company debt level
How much debt Ligand Pharmaceuticals, Inc. have in comparison to other dividend stocks
Become our supporter to unlock all data!
Ligand Pharmaceuticals, Inc. description

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M.

Evans in 1987 and is headquartered in San Diego, CA.

Company profile
Market cap
Small (1.78B)
Company CEO
John L. Higgins
Price history Ligand Pharmaceuticals, Inc.
Loading price stock history...
LGND dividends payouts
Similar stocks as Ligand Pharmaceuticals, Inc.